Literature DB >> 34982576

DNA-PK promotes activation of the survival kinase AKT in response to DNA damage through an mTORC2-ECT2 pathway.

Liu Liu1,2, Xiaoming Dai3, Shasha Yin1,2, Pengda Liu4, Elizabeth G Hill2,5, Wenyi Wei3, Wenjian Gan1,2.   

Abstract

The kinase AKT (also known as protein kinase B) is a key regulator of cell proliferation, survival, and metabolism. In addition to being activated by growth factors, AKT is activated in response to DNA damage. Here, we found that the DNA damage response kinase DNA-PK sustains cell survival through a phosphorylation event that leads to increased AKT activity. In various cancer and noncancer cells in culture, DNA damage caused by ionizing radiation or topoisomerase inhibitors triggered DNA-PK–dependent phosphorylation of the mTOR complex 2 (mTORC2) subunit Sin1, which enabled its interaction with the guanine nucleotide exchange factor ECT2. Depleting Sin1 or ECT2 or disrupting the protein interaction or catalytic function of ECT2 attenuated DNA damage–induced AKT activation, thereby enhancing cellular sensitivity to DNA-damaging agents. Our findings elucidate a mechanism mediating DNA damage–induced AKT activation and cell survival.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34982576      PMCID: PMC8992387          DOI: 10.1126/scisignal.abh2290

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   9.517


  72 in total

1.  Delayed mammary gland involution in MMTV-AKT1 transgenic mice.

Authors:  Scott Ackler; Shakeel Ahmad; Christopher Tobias; Michael D Johnson; Robert I Glazer
Journal:  Oncogene       Date:  2002-01-10       Impact factor: 9.867

Review 2.  The PI3K Pathway in Human Disease.

Authors:  David A Fruman; Honyin Chiu; Benjamin D Hopkins; Shubha Bagrodia; Lewis C Cantley; Robert T Abraham
Journal:  Cell       Date:  2017-08-10       Impact factor: 41.582

3.  Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity.

Authors:  Qian Yang; Ken Inoki; Tsuneo Ikenoue; Kun-Liang Guan
Journal:  Genes Dev       Date:  2006-10-15       Impact factor: 11.361

Review 4.  Activation of AKT kinases in cancer: implications for therapeutic targeting.

Authors:  Alfonso Bellacosa; C Chandra Kumar; Antonio Di Cristofano; Joseph Robert Testa
Journal:  Adv Cancer Res       Date:  2005       Impact factor: 6.242

Review 5.  mTOR Signaling in Growth, Metabolism, and Disease.

Authors:  Robert A Saxton; David M Sabatini
Journal:  Cell       Date:  2017-03-09       Impact factor: 41.582

Review 6.  The TSC1-TSC2 complex: a molecular switchboard controlling cell growth.

Authors:  Jingxiang Huang; Brendan D Manning
Journal:  Biochem J       Date:  2008-06-01       Impact factor: 3.857

7.  DNA end-independent activation of DNA-PK mediated via association with the DNA-binding protein C1D.

Authors:  U Yavuzer; G C Smith; T Bliss; D Werner; S P Jackson
Journal:  Genes Dev       Date:  1998-07-15       Impact factor: 11.361

8.  Human ECT2 is an exchange factor for Rho GTPases, phosphorylated in G2/M phases, and involved in cytokinesis.

Authors:  T Tatsumoto; X Xie; R Blumenthal; I Okamoto; T Miki
Journal:  J Cell Biol       Date:  1999-11-29       Impact factor: 10.539

9.  Phosphorylated Rho-GDP directly activates mTORC2 kinase towards AKT through dimerization with Ras-GTP to regulate cell migration.

Authors:  Hiroshi Senoo; Yoichiro Kamimura; Reona Kimura; Akihiko Nakajima; Satoshi Sawai; Hiromi Sesaki; Miho Iijima
Journal:  Nat Cell Biol       Date:  2019-07-01       Impact factor: 28.824

10.  Dynamic adipocyte phosphoproteome reveals that Akt directly regulates mTORC2.

Authors:  Sean J Humphrey; Guang Yang; Pengyi Yang; Daniel J Fazakerley; Jacqueline Stöckli; Jean Y Yang; David E James
Journal:  Cell Metab       Date:  2013-05-16       Impact factor: 27.287

View more
  3 in total

1.  A p53-phosphoinositide signalosome regulates nuclear AKT activation.

Authors:  Vincent L Cryns; Richard A Anderson; Mo Chen; Suyong Choi; Tianmu Wen; Changliang Chen; Narendra Thapa; Jeong Hyo Lee
Journal:  Nat Cell Biol       Date:  2022-07-07       Impact factor: 28.213

2.  The PIKK-AKT connection in the DNA damage response.

Authors:  Sejeong Shin; Katherine A Walker; Sang-Oh Yoon
Journal:  Sci Signal       Date:  2022-01-04       Impact factor: 9.517

Review 3.  Development and Evolution of DNA-Dependent Protein Kinase Inhibitors toward Cancer Therapy.

Authors:  Yoshihisa Matsumoto
Journal:  Int J Mol Sci       Date:  2022-04-12       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.